GENELUX Corp - GNLX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 02, 2026 | — | S | D | 12,000.0 | 2.9082 | 34,898.4 | 91,403.0 | View | |
| Jun 18, 2026 | Chief Financial Officer | A | A | 278,906.0 | 0.0 | 0.0 | 278,906.0 | View | |
| Jun 18, 2026 | General Counsel | A | A | 233,957.0 | 0.0 | 0.0 | 233,957.0 | View | |
| Jun 18, 2026 | Chief Technical Officer | A | A | 174,841.0 | 0.0 | 0.0 | 329,390.0 | View | |
| Jun 18, 2026 | — | A | A | 31,566.0 | 0.0 | 0.0 | 31,566.0 | View | |
| Jun 18, 2026 | — | A | A | 28,409.0 | 0.0 | 0.0 | 96,483.0 | View | |
| Jun 18, 2026 | President and CEO | A | A | 730,601.0 | 0.0 | 0.0 | 1,263,913.0 | View | |
| Jun 18, 2026 | — | A | A | 31,566.0 | 0.0 | 0.0 | 31,566.0 | View | |
| Jun 18, 2026 | — | A | A | 28,409.0 | 0.0 | 0.0 | 501,193.0 | View | |
| Jun 18, 2026 | — | A | A | 31,566.0 | 0.0 | 0.0 | 31,566.0 | View | |
| Jun 18, 2026 | — | A | A | 28,409.0 | 0.0 | 0.0 | 102,693.0 | View | |
| Jun 18, 2026 | Chief Scientific Officer | A | A | 119,318.0 | 0.0 | 0.0 | 269,024.0 | View | |
| Jun 18, 2026 | — | A | A | 31,566.0 | 0.0 | 0.0 | 31,566.0 | View | |
| Jun 18, 2026 | — | A | A | 28,409.0 | 0.0 | 0.0 | 103,403.0 | View | |
| Jun 04, 2026 | Head of Regulatory | S | D | 192.0 | 2.93 | 562.56 | 67,611.0 | View | |
| Jun 02, 2026 | — | S | D | 10,000.0 | 2.9801 | 29,801.0 | 472,784.0 | View | |
| May 12, 2026 | Chief Technical Officer | S | D | 605.0 | 2.9742 | 1,799.39 | 154,549.0 | View | |
| May 12, 2026 | Chief Scientific Officer | S | D | 605.0 | 2.9726 | 1,798.42 | 149,706.0 | View | |
| May 12, 2026 | President and CEO | S | D | 2,798.0 | 2.9398 | 8,225.56 | 532,051.0 | View | |
| May 12, 2026 | Head of Regulatory | S | D | 270.0 | 2.9796 | 804.49 | 67,803.0 | View | |
| Mar 26, 2026 | SVP, Clinical Development | S | D | 906.0 | 2.42 | 2,192.52 | 144,938.0 | View | |
| Mar 26, 2026 | Chief Technical Officer | S | D | 906.0 | 2.42 | 2,192.52 | 155,154.0 | View | |
| Mar 26, 2026 | Head of Regulatory | S | D | 240.0 | 2.51 | 602.4 | 68,073.0 | View | |
| Mar 26, 2026 | Head of Regulatory | S | D | 345.0 | 2.42 | 834.9 | 68,313.0 | View | |
| Mar 26, 2026 | President and CEO | S | D | 3,582.0 | 2.42 | 8,668.44 | 534,849.0 | View | |
| Mar 03, 2026 | — | S | D | 10,000.0 | 2.8957 | 28,957.0 | 482,784.0 | View |